Avidity Biosciences
RNA
#1888
Rank
C$15.40 B
Marketcap
C$99.71
Share price
-0.23%
Change (1 day)
128.77%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$15.40 Billion

As of February 2026 Avidity Biosciences has a market cap of C$15.40 Billion. This makes Avidity Biosciences the world's 1888th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026C$15.40 B3.49%
2025C$14.88 B188.72%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Feb 24th, 2026 the market cap of Avidity Biosciences was reported to be:

C$15.02 Billion
by Nasdaq info icon info icon
C$15.40 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$211.48 B 1,273.07%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$162.59 B 955.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.70 B-82.43%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$7.59 B-50.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.25 B-98.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.12 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$14.98 B-2.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.07 B-73.54%๐Ÿ‡บ๐Ÿ‡ธ USA